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Abstract 
 
Bacterial peptidoglycan is constructed by cross-linking sugar chains carrying pentapeptide 
building blocks with two D-alanine residues at the C-terminus. Incorporation into the polymer 
and subsequent breakdown of peptidoglycan releases a tetrapeptide with a single D-alanine 
residue. Removal of this residue is necessary for the tripeptide to receive a new D-Ala-D-Ala 
dipeptide in the synthetic pathway, but proteases are generally unable to work with substrates 
having residues of unusual chirality close to the scissile bond. Processing of the tetrapeptide is 
carried out by a dedicated LD-carboxypeptidase, which is of interest as a novel drug target. We 
describe the high resolution crystal structure of the enzyme from E. coli, and demonstrate the 
dimeric structure is highly  conserved. 
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Introduction 
 
 Both Gram positive and Gram negative bacteria possess a cell wall that includes a 
protective layer of peptidoglycan (PG), built from sugar chains cross-linked via short peptides.  
Synthesis involves adding fresh units consisting of a disaccharide with an attached 
pentapeptide that generally terminates with two D-alanine residues. In Gram negative species 
the peptide has the sequence L-Ala-g-D-Glu-m-A2pm-D-Ala-D-Ala, where m-A2pm stands 
for meso-diamopimelic acid [1, 2]. Penicillin-binding proteins (PBPs) [3] are a large group of 
proteins responsible for the transpeptidation reaction that cross-links the peptides, and also 
include non-essential enzymes that trim the peptides, and so help to shape the cell and also 
recycle PG components [4, 5]. The importance of PG to bacteria is underlined by the fact that 
numerous antibiotics, including the penicillins, function by blocking key enzymes involved in 
its synthesis. Penicillin and its analogues mimic the D-alanine residues to make suicide 
substrates  [6]. 
 PG is continually reworked as the cell grows and divides [7-9], so that during 
exponential growth bacterial cells release a considerable quantity of PG break-down products 
into the growth medium. Some of these cell-wall fragments function as messengers, for 
example as triggers of immune responses; the mammalian protein NOD1 detects specific PG 
fragments [10, 11], initiating inflammatory responses. Hydrolases are found that can break 
each of the glycosidic or amide bonds in PG, and many appear to have overlapping roles [3, 
12]. This creates a functionally redundant system that is robust to mutation or chemical 
inhibition, and allows the cell to re-use much of the material in fresh PG synthesis. Lytic 
transglycosylases and endopeptidases release anhydromuropeptides that are transported into 
the cell by the AmpG permease before further degradation through the action of N-
acetylglucosaminidase (NagZ), N-acetylmuramyl-L-alanine amidase (AmpD) and L,D-
carboxypeptidase (LdcA) [12]. LdcA uniquely cleaves the peptide bond between the third and 
fourth residues of the tetrapeptide, releasing the C-terminal D-alanine [13].  
 It is estimated that about half of the PG breakdown products are recaptured in this way, 
to offset the very considerable metabolic cost of PG synthesis [14]. Growth in rich media 
affords bacteria the luxury of building PG entirely de novo, so that loss of recycling pathways 
does not impact the speed of cell multiplication. Both Gram positive and negative cells 
however are found to lyse in stationary phase if recycling is blocked [15, 16]. This discovery 
has prompted efforts to develop specific inhibitors of LdcA for use as anti-bacterial agents with 
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an entirely novel mechanism of action, and high-throughput screening conducted some years 
ago produced a lead candidate [17]. Since then it has become clear that PG recycling plays an 
important role in triggering the expression of beta-lactamase in pathogenic Pseudomonas, and 
further that strong impairment of PG recycling may severely weaken both fitness and virulence 
[18, 19]. Given the interest in LdcA as a possible novel drug target, different groups have 
determined crystal structures of the protein from Pseudomonas aeruginosa [20] and 
Novosphingobium aromaticuvorans [21]. These models show the protein is a member of the 
Peptidase_S66 family (Pfam family PF02016). This family includes the self-immunity protein 
MccF, whose structure has also been solved by X-ray crystallography [22]. The oligomeric 
state of NaLdcA appears to be dimeric from the crystal structure, but size-exclusion 
chromotography indicated a monomer [21]. E. coli LdcA shows significant sequence 
differences from the known structures, and includes sequence insertions that might be involved 
in formation of homo- or hetero-oligomer formation (Supplementary Figure 1). To clarify these 
issues we have solved the crystal structure of EcLdcA and a mutant at the active site. 
 
Materials and Methods 
Cloning 
 The wild-type E.coli ldcA gene was amplified from genomic DNA by PCR, and cloned 
into pET-28b expression vector between the restriction sites NdeI and BamH1 to allow 
expression of recombinant protein with a hexa-histidine tag at the N-terminus, cleavable with 
thrombin. The PCR product before and after restriction enzyme treatment was purified using 
Nippon Genetics Purification Kit. The insert DNA was ligated into the cut vector using T4 
DNA ligase at 16℃ for 3 hours before transformation for plasmid preparation. To introduce 
the site-directed mutation S106A using PCR the following primers were used: 
GCTCATTTGCGGACATGCGGATTTTACCGCCATTC and 
GAATGGCGGTAAAATCCGCATGTCCGCAAATGAGC. The expression vector for the 
mutant protein was produced in the same way as the wild-type. 
 
Expression and purification 
 The pET-28 plasmid with ldcA was transformed into E. coli BL-21(DE21) cells and the 
cells were grown at 37℃ with shaking in 1 L LB medium containing kanamycin (20μg ml-1). 
When the OD600 of the culture reached 0.6, protein expression was induced by adding IPTG to 
a final concentration of 0.5 mM and growth was continued overnight at 20℃. The cells were 
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collected by centrifugation at 4600 g at 4℃ for 20 min. The pellet was suspended in 10 ml 
50 mM Tris-HCl pH 8.5 and 50 mM NaCl per 1 L culture and then lysed by sonication on ice. 
The lysate was centrifuged at 48000 g at 4℃ for 30 min. The supernatant was micro-filtered 
before loading onto a 15 ml nickel Sepharose column equilibrated with 50 mM Tris-HCl pH 
8.5, 50 mM NaCl and 10 mM imidazole. After washing, the protein was eluted with 50 mM 
Tris-HCl pH 8.5, 50 mM NaCl and 250 mM imidazole. After dialysis the protein was loaded 
onto a HiTrap Q HP column equilibrated with 50 mM Tris-HCl pH 8.5, and eluted with a salt 
gradient to 1 M NaCl. The pooled fractions containing LdcA were concentrated and loaded 
onto a gel filtration column equilibrated with 50 mM Tris-HCl pH 8.5 and 50 mM NaCl. The 
eluted protein was concentrated to 12 mg ml-1 using Amicon centrifugal filter units. The same 
protocol was used to express and purify the mutant LdcA. 
 
Crystallisation and data collection 
 Purified protein, both native and mutant, was crystallised by vapor diffusion using the 
hanging-drop method. The reservoir solution (12% (w/v) PEG 3350, 0.2 M sodium thiocyanate, 
20 mM TrisHCl pH 8.5) was mixed in a 1:1 ratio with the protein, and the drop then 
equilibrated against 0.5 mL of reservoir solution at 20℃. A separate crystal form (used for 
heavy atom soaks) was grown using 85 mM HEPES pH 7.5, 3.66 M sodium chloride and 15% 
glycerol. Diffraction data used for the final refinements were collected from crystals held at 
100K at BL17A of the Photon Factory, Tsukuba using a PILATUS-2M detector. Data 
processed with XDS [23]. Initial structure solution was performed using PHENIX [24], and 
data manipulation was performed with the CCP4 suite [25]. Refinement was carried out with 
REFMAC [26] and COOT [27]. All data collection and refinement statistics are shown in 
Supplementary Table 1. The structures and X-ray data were deposited in the Protein DataBank 
and assigned the identifiers PDB: 5Z01 (native) and PDB: 5Z03 (mutant). 
 
Results 
Native crystal structure 
 The cloning, expression and purification of native LdcA were carried out as described 
in the Materials and Methods section. The protein crystallised in space group I222 and P3212. 
The former crystals, grown in PEG 3350, diffracted to 1.75 Å at beam-line BL17A of the 
Photon Factory, but the trigonal crystals (grown in sodium chloride) gave weaker data to a 
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maximum resolution of only 2.54 Å. The trigonal crystals however proved robust to soaking 
with ethyl-mercury-p-toluenesulphanilide, allowing SAD phasing with a single dataset 
collected at BL5A using a wavelength of 1.00659 Å. Five mercury sites could be identified 
and reliably refined using the Autosol [28] procedure of PHENIX [24]. Automatic model 
building produced a largely connected structure of 248 residues with R-factor/Rfree of 33.26% 
and 38.67%. PHASER [29] was used to place this search model in the space group  and cell of 
the native data, giving rotation and translation scores (RFZ and TFZ) of 12.5 and 15.7 
respectively. Manual improvements were carried out using COOT [27], giving a model with a 
single continuous chain of 305 residues and 212 water molecules. The data collection and final 
refinement statistics are given in Supplementary Table 1. The N-terminal histidine tag proved 
difficult to remove with thrombin and so this step was dropped from the purification protocol, 
but only a few residues of the tag are visible in the electron density. The Ramachandran plot 
shows Ser 10 and Ser 106 have unusual backbone angles; the latter residue is the catalytic 
serine, but even this is not considered an outlier by Molprobity [30]. The f/y angles of 68° and 
129° are energetically unfavourable, but typical for serine proteases. Some side-chains show 
unusual rotamers, which can mostly be explained by the fact these are surface residues with no 
strong side-chain interactions. One exception is Arg 41, which makes strong hydrogen bonds 
with Asp 56, both residues being very well defined in the electron density. 
 
 EcLdcA has a mixed a/b structure with two b sheets, one highly twisted and surface 
exposed, and the other being sandwiched between a helices (Figure 1). A search for similar 
models using the monomer model and DALI [31] gave a list of related structures, with the most 
strongly related (PDB: 3TLB) having a Z-score of 35.9 and 26% sequence identity. This model 
is of the self-immunity protein MccF, a serine carboxypeptidase that hydrolyzes a natural 
antimicrobial compound called microcin C7 [22]. The catalytic triads of both enzymes overlay 
closely, although the active site serine of the MccF model (PDB: 3TLB) has been replaced with 
alanine so that a substrate peptide can bind without undergoing hydrolysis. Overlaying EcLdcA 
with MccF using the automated procedure SSM [32] shows that 256 core residues of the two 
models may be aligned with an rmsd of 1.76 Å. The similarity of the two models is highlighted 
in Supplementary Figure 2. The principal difference between them is an insertion from residue 
174 to 202 in MccF (equivalent to residues 158 and 160 in EcLcdA), which creates a long loop 
stretching towards the active site. Trp 186 of MccF provides a contact with the substrate, the 
adenine ring of C7 stacking against it. The peptide substrates of LdcA homologues have no 
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such feature, and the presence or absence of this loop appears to be related to the substrate 
specificity. Overall the chain trace of the EcLdcA and MccF models is highly similar, reflecting 
the high level of sequence identity (29.8%). The EcLdcA model shows greater similarity to 
this structure than PaLdcA or NaLdcA because of more complete secondary structure. The 
second b sheet is largely absent from the NaLdcA model (PDB: 3G23 [21]), and the PaLdcA 
model (PDB: 1ZRS [20]) terminates in the centre of the final strand, whereas the EcLdcA 
model described here extends for a further 7 residues. The PaLdcA model in contrast is 
disordered around the loop preceding helix a5. Notably all the LdcA models and MccF share 
the same dimer structure (Figure 2). For the EcLdcA model, PISA [33] reports a dimer interface 
that buries a surface area of roughly 1700 Å2. Overall 48 residues contact the partner chain, the 
dimer interactions including four salt-bridges (Arg 81-Glu 210, Arg 85-Asp 257) with 
equivalents in NaLdcA but not PaLdcA. 
 
Structure of the S106A mutant 
 The active site serine (Ser 106) of EcLdcA is found within a highly conserved motif 
(Supplementary Figure 1). The site-directed mutant of EcLdcA missing the catalytic serine was 
created in order to help produce crystal structures of a substrate complex. Unexpectedly, loss 
of the side-chain hydroxyl group altered the crystallization behavior of the protein, and the 
same crystallization conditions were found to produce crystals in an orthogonal space-group, 
with some indications of pseudo-translation in the Patterson map. Molecular replacement 
permitted a clear solution in only P21212. The new crystal form diffracts to the same resolution 
as the native, and contains a dimer in the asymmetric unit, with 283 or 284 ordered residues 
per subunit. Residues 12-13, 43-48, 235-243 and 304-305 are missing from each subunit, with 
some other residues contiguous with these gaps also absent from one or other protein chain. 
Some differences may be due to crystal contacts (residues 240 and 244 making crystal contacts 
in the native model). The active site itself shows no marked deviations directly due to the 
mutation, and the missing residues are all at least 10 Å from the catalytic serine. Both Gly 75 
and Gly 76 are highly ordered in the native structure but seem to be rather more flexible in the 
mutant, with Gly 75 undergoing a peptide flip (Supplementary Figure 3). These residues lie 
opposite the catalytic serine, so that the carbonyl of Gly 75 in the mutant model would clash 
with a bound substrate. On the opposite side of the substrate pocket, Ile 202 adopts a rather 
different position in the two models, probably as a result of flexibility in the 235-243 loop of 
the mutant. In the native model it lies against His 270 of the catalytic triad, and probably holds 
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it in place throughout catalysis. Movement of this residue provides a possible catalytic control 
mechanism by partner proteins engaging with the 235-243 loop at the surface. There is no 
evidence of anything in the active site of the mutant apart from weakly held water molecules, 
in contrast to the native protein, as described below. 
 
Active site 
 Comparing the active sites of different models it can be seen that the active site of the 
LdcA homologues is highly conserved. NaLdcA (PDB: 3G23) shows the same peptide flip at 
Gly 75 of the EcLdcA mutant. Ala 72 and Phe 108 of EcLdcA are found to be swapped in 
NaLdcA. All the LdcA models show one conserved arginine residue from each subunit 
(equivalent to Arg 211 of EcLdcA) extending towards the active site of the partner chain 
(Supplementary Figure 4). This feature is also found in MccF. The active site of native EcLdcA 
is found to hold a significant volume of electron density which cannot easily be reconciled with 
any solvent molecules present. The maximum peak of difference density reaches 11 s, 
although the 2mFo-DFc map reaches only just over 3 s, and has a ring-like shape 
(Supplementary Figure 5). For comparison, the map for the mutant is shown in Supplementary 
Figure 6. The position but not the shape overlaps with the ligand in the MccF structure. The 
only apparent candidate molecules to fill the active site of the crystal structure are water 
molecules, but these have been left unmodelled due to the unusual nature of the density. 
In order to observe any bound ligand, several attempts were made using cell-wall 
derived peptides to detect a complex by electro-nanospray ionisation mass spectrometry (ESI).  
These data indicated a covalent modification of the EcLcdA, with a mass increment of 178 Da 
over the expected value (Figure 3). However, since the histidine tag was not removed, this 
covalent adduct can be ascribed to a known gluconoylation reaction of the tag, and not the 
active site of the protein [34]. The only commercially available cell wall peptide is the 
pentapeptide of the kind found in Gram positive bacteria, with a lysine residue at the third 
position. Since the tetrapeptide is the true substrate, and activity on the pentapeptide is very 
low at best, PBP4 (DacB) from E. coli was purified as described previously [35], and used to 
remove the C-terminal residue. Neither mass spectrometry nor crystal soaking yielded any 
evidence of binding however, indicating that the third residue may provide important contacts. 
Antibiotics that operate through inhibition of LdcA may therefore prove to be highly specific 
for Gram positive or negative species. 
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Molecular weight 
 The ESI data indicated that EcLdcA forms a stable dimer under low salt conditions, 
which is consistent with the large interfacial area seen in both the mutant and wild-type crystal 
structures. Some uncertainty arose with the publication of the NaLdcA crystal structure, since 
the size-exclusion data of Das and colleagues [21] suggested the protein to be a monomer in 
solution. To confirm that the protein is indeed dimeric we performed analytical 
ultracentrifugation sedimentation velocity experiments with EcLcdA in 100 mM salt to 
reproduce the conditions of the gel filtration experiment (Figure 4). The analysis shows no 
evidence for any form other than the dimer, and it seems most likely that the published size-
exclusion experiment is in error, probably as a result of the distinctly non-spherical shape of 
the protein. 
 
Discussion 
 Despite the overall conservation of the fold and sequence, variations clearly exist 
among the forms of LdcA found in different microbial species, and the oligomeric form of the 
protein remained uncertain. The crystallographic and other biophysical studies reported here 
with E. coli LdcA provide strong grounds for believing the protein is universally a dimer. The 
fact that LdcA is not invariably essential, and the cytoplasmic location of the enzyme in most 
bacteria, detracts from its promise as a drug target, but we hope that the model and other data 
presented here assist efforts to find clinically useful inhibitors. The recent discovery that 
gonococcal LdcA may have an outer membrane lipoprotein form suggests that Neisseria could 
benefit from inflammatory responses mediated by the peptidoglycan-sensing protein NOD1, 
possibly by allowing the bacteria to manipulate apoptosis and autophagy [36]. The flexibility 
of the enzyme around the active site was not expected, and the different crystallisation 
behaviour of the native protein and the mutant with alanine in place of the active site serine is 
unprecedented to the best of our knowledge. This flexibility probably contributes to the fact 
that structural analysis of a substrate complex of the protein has yet to be reported. 
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Figure legends 
 
Figure 1. 
(a) A ribbon diagram showing the trace of a single subunit of EcLdcA. Residues conserved 
among the known LdcA models are shown in red. The catalytic triad at the active site (Ser 106, 
His 105, Glu 200) is shown as sticks, with carbon atoms shown in yellow, oxygen red and 
nitrogen blue. (b) The same ribbon diagram coloured from blue (N-terminus) to red (C-
terminus). 
 
Figure 2. 
(a) A stereo ribbon diagram of native EcLdcA, looking along the dyad axis of the dimer, with 
the left-hand subunit coloured as a spectrum from N to C-terminus, and the right-hand subunit 
in light green. (b) The catalytic triad of the left-hand subunit and the conserved Arg 211 of the 
opposite subunit are shown as sticks. (c) A ribbon diagram of NaLdcA, seen in the same 
orientation as the EcLdcA in (a), with the subunits coloured brown or green. The absence of 
the second b sheet in both subunits due to disorder is apparent.  
 
Figure 3. 
(a) The raw electrospray mass spectrum of denatured EcLdcA in 0.1% trifluroacetic acid/40% 
acetonitrile, showing the peaks due to the principal species with mass 35600.61 Da and 
secondary peaks indicating a covalent adduct creating a species with mass 35778.53 Da. (b) 
Analysis shows only these two species are present in the sample. The larger mass is consistent 
with spontaneous N-6-phosphogluconoylation of the histidine tag. The mass spectrum was 
obtained with a SYNAPT G2 HDMS mass spectrometer (Waters). 
 
Figure 4. 
A plot of relative species concentration versus molecular weight, determined by sedimentation 
velocity using a rotor speed of 40,000 rpm. The calculated mass average for native EcLdcA is 
69 kDa, with no indication of any species in solution other than the dimer. Data were analysed 
using SEDFIT [37]. 
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Supplementary material 
 
Figure S1.  
A sequence alignment of E. coli LdcA with the proteins from Novosphingobium 
aromaticuvorans and Pseudomonas aeruginosa. Conserved residues are highlighted in 
white-on-red. Corresponding structural elements of the E. coli model are shown as helices and 
arrows over the sequence. 
 
 
                              .                       TT                   EcLdcA
          1       10        20         30        40        50        60    
EcLdcA                  AP                                      AG    RL          L   A I L   T   ..........MSLFH I SGYCIKQHA L.RG QR TDAGHQVNNVEVIARRCERF ETE EDLNSLARLT
NaLdcA                  AP                                      AG    RL          I   A L A   S   ........GMTRRIA C STPFTREDS RVIA AA EFPDLSLSFHEQCFASEGHF DAL SAFLECAN.D
PaLdcA                  AP                                      AG    RL          L   L L L   T   PSSDQTWQPIDGRVA I ASAIAT.EV E.AT RQ EVHGVDYHLGRHVEARYRYL VEQ EDLHNAFDMP
 TT                                                                        EcLdcA
    70        80        90       100       110       120       130         
EcLdcA      V   RGGYG              A          G SD          H        P            I V     LL I     I   M DTPNT LA ASR AD DWQALV RQQHDPLLIC H FTA QCGLLA GNVITFSG LVANFGA. EL
NaLdcA      V   RGGYG              A          G SD          H        P            A V     IA A     L   M EDAFE WF ANR ED LARLGR A...SAKQYL Y AGT LAALYA RIGRSVHA PVDIR.RP GE
PaLdcA      V   RGGYG              A          G SD          H        P            A L     LL L     L   V E.DIT WC CGQ PG DWGRLE ASP...RPLI F ISV LSAFHR GL.PAIHG ATG.LGLQ RL
                                                TT                         EcLdcA
140       150       160       170       180        190       200       210  
EcLdcA          LA                          NL  L    GT              E   E      R   A L    I L   ILVL DI  F VE NAFTEHHFW LRNETFTIEWQGEGPTCR EGT WGG AM S I PWM.PKIENG N HP R M
NaLdcA          LA                          NL  L    GT              E   E      R   L A    A L   VVMI EV  Y VD SAVRRTLGW GAREGLEPT......... GAP VAF MT M C .RLLPDLSGH A HH A L
PaLdcA          LA                          NL  L    GT              E   E      R   V L    A M   ILVL DV  Y LE ASLASVSRL GIDHELPVQ.HLGGHKQR EGA IGG TA C A LGGLHAPAGS G PY R S
                                                                           EcLdcA
     220       230       240       250       260       270       280       
EcLdcA L                LG                E                    GH       P G        L I   S D NL V L I L   T   LQ YHAGILPRQKA I SF GSTPN YDAGY S YAFLRSR S PLITG DF EQR VTL L AHAILNN
NaLdcA L                LG                E                    GH       P G        V L   S D SV M A I A   N   FH TSCLADAGIAG R RV DVPEN RPFGC E ARHWCHR G AFLGT DI DVD RIV F .......
PaLdcA L                LG                E                    GH       P G        L I   T E SL I I V L   N   WQ LESIDARQLGA C SF DCPRK V..AH R FGEYAAA E PLYHH PS GAQ RAW Y KTAVLEG
 TT                                                                        EcLdcA
290       300                                                              
EcLdcA TTRETQLTISGHPVLKZ                                                          
NaLdcA .................                                                          
PaLdcA NRLRW............                                                          
β1 α1 β2 η1 α2 η2 
β3 η3 α3 β4 η4 α4 β5 π1 
α5 β6 β7 α6 β8 α7 
η5 β9 η6 α8 β10 β11 β12 
β13 
 
  
Figure S2.  
A least-squares overlay of ribbons representing one subunit of EcLdcA (beige) and MccF 
(purple), shown in stereo. The extended loop of MccF carrying Trp 186 is shown, and the 
tryptophan side-chain is shown as sticks. The catalytic triad of EcLdcA is shown as sticks 
with carbon atoms coloured yellow, oxygen red and nitrogen blue. 
 
  
Figure S3.  
A stereo figure showing the active site of native EcLdcA (carbon atoms in yellow), 
superposed with the S106A mutant (with carbon atoms orange). Loss of the active site serine 
side-chain causes marked main-chain shifts on either side of the active site, notably Gly 75. 
 
 
 
 
 
  
Figure S4.  
A stereo figure showing the active site of native EcLdcA (carbon atoms in yellow for one 
subunit, and in pink for the other). Arg 211 approaches within 8 Ångstroms of the active site 
serine of the partner subunit. This conserved residue is close enough to bind substrate, 
suggesting that the dimer is the active form of the enzyme, and the arginine plays some role in 
substrate interaction. 
 
 
 
 
 
 
  
Figure S5. 
The 2mFo-DFc electron density map over the catalytic triad of the active site in native 
EcLdcA, contoured at 1 s, shown in stereo. Density extending from the active site serine 
side-chain is found, but mass spectrometry indicates no covalently attached species. The 
active site density was left unmodelled. 
 
 
 
 
 
 
  
Figure S6. 
The 2mFo-DFc electron density map over the catalytic triad of the active site in mutant 
S106A EcLdcA, contoured at 1 s, shown in stereo.  
 
 
 
 
 
 
 
  
Supplementary Table 1. Data collection and structure refinement 
 
_____________________________________________________________________________ 
     Data Set     Native    S106A mutant  
    PDB 5Z01 PDB 5Z03  
_____________________________________________________________________________ 
Resolution range (Å) 46.9 – 1.75  46.7 – 1.75     
 Space group   I222  P21212   
 Unit cell dimensions (Å)    a=77.9 b=89.0, a=68.8 b=93.4,           
    c=93.8  c=86.8   
Reflections (Measured/Unique)  300,303 / 33,235 363,628 / 56,189   
 Completeness (%)   99.9 / 99.9  99.1 / 85.0    
 Mean <I> / <s(I)>    19.4 / 2.2  11.2 / 2.0             
 Multiplicity   9.0 / 9.3    6.5 / 5.5      
 Rmerge (%)a   7.3 / 101.6  9.7 / 83.2      
 B factor from Wilson plot (Å2)    23.5  19.9   
 cc1/2 (%)                             99.9 / 88.9           99.9 / 49.1  	 	   
Refinement Statistics          
Resolution range (Å)   46.9 – 1.75  46.7 – 1.75   
R-factorb / free R-factor (%)  17.9 / 22.5  22.9 / 27.0   
Rms deviations from ideals 
   bond lengths (Å) / bond angles (°) 0.02 / 1.80  0.019 / 1.90 
No. of water atoms   212  56   
B-values (all atoms, Å2) 
   protein/water   30.0 / 34.5  33.4 / 27.7   
Ramachandran plot           
   residues in most favorable regions   293  533       
   residues in allowed regions   10  35     
   residues in outlier regions   0  1     
_____________________________________________________________________________ 
 
Values in outer shell are for the highest shell with resolution limits of 1.79-1.75 Å. 
aRmerge =S | Ii - <I> | / S | Ii | , where Ii is the intensity of an observation and <I> is the mean value for that reflection 
and the summations are over all reflections. Free R-factor was calculated with 5% of the data.  
bR-factor =S h||Fo(h)| - |Fc(h)|| / ShFo(h), where Fo and Fc are the observed and calculated structure factor amplitudes, 
respectively. 
 
 
 
